To include your compound in the COVID-19 Resource Center, submit it here.

Cancer

INDICATION: Breast cancer; ovarian cancer; prostate cancer

Cell culture and mouse studies suggest combining PARP and BET bromodomain proteins inhibitors could help treat homologous recombination

Read the full 242 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE